Stanford Health Care is First in the Western U.S. to Complete Transapical Off-Pump Mitral Valve Repair
CARE AT STANFORD
Our highly trained, experienced specialists and surgeons offer leading-edge care for the full spectrum of complex conditions.
Stanford Health Care is accepting candidates for the NeoChord DS1000 clinical trial (ReChord), with Boyd as principal investigator. Patients must have moderate or severe degenerative mitral valve regurgitation. Learn more.
About Stanford Health Care
Stanford Health Care seeks to heal humanity through science and compassion, one patient at a time, through its commitment to care, educate and discover. Stanford Health Care delivers clinical innovation across its inpatient services, specialty health centers, physician offices, virtual care offerings and health plan programs.
Stanford Health Care is part of Stanford Medicine, a leading academic health system that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children’s Health, with Lucile Packard Children's Hospital. Stanford Medicine is renowned for breakthroughs in treating cancer, heart disease, brain disorders and surgical and medical conditions. For more information, visit: www.stanfordhealthcare.org.